Senior Director, Analytical Sciences and Quality Control
-
Kok-Seong Lim, BPharm, PhD, is a pharmaceutical leader with over 20 years of experience in biological research and development, specializing in analytical sciences, quality control, and CMC strategy for advanced therapy platforms. He has held multiple management roles at Metagenomi, Aura Biosciences, Editas Medicine, and Thermo Fisher Scientific (formerly Brammer Bio), where he contributed to the advancement of more than 10 gene therapies and CRISPR-based medicines for rare diseases and oncology indications. Throughout his career, Kok-Seong has led the buildout of GMP-compliant facilities and analytical infrastructures to support early- and late-stage development. He has successfully managed complex, multimillion-dollar budgets and contributed to regulatory submissions in both the U.S. and EU. An active industry contributor, Kok-Seong regularly presents at conferences and has served on committees such as the U.S. Pharmacopeia Expert Committee on Biologics - Cell and Gene Therapies and the Standards Coordinating Body, helping to shape best practices and standards for the field. He earned his PhD in Biochemistry from the National University of Singapore and a BSc in Pharmacy from the University of Strathclyde.
Accelerating Cell Therapy Development: Challenges and Opportunities
Wednesday, October 8, 2025
2:15 PM - 3:15 PM EST